CLINIDERM Trademark

Trademark Overview


On Tuesday, October 18, 2022, a trademark application was filed for CLINIDERM with the United States Patent and Trademark Office. The USPTO has given the CLINIDERM trademark a serial number of 97636575. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 14, 2025. This trademark is owned by Accelera Pharma Canada Inc.. The CLINIDERM trademark is filed in the Cosmetics & Cleaning Products and Pharmaceutical Products categories with the following description:

Medicated topical creams and lotions for treating skin conditions

Cosmetic topical creams and lotions for non-medical use
cliniderm

General Information


Serial Number97636575
Word MarkCLINIDERM
Filing DateTuesday, October 18, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements


Goods and ServicesMedicated topical creams and lotions for treating skin conditions
Goods and ServicesCosmetic topical creams and lotions for non-medical use

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 1, 2022
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAccelera Pharma Canada Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5L5Z9
CA

Party NameAccelera Pharma Canada Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5L5Z9
CA

Trademark Events


Event DateEvent Description
Friday, October 21, 2022NEW APPLICATION ENTERED
Friday, October 21, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, November 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2022ASSIGNED TO LIE
Monday, December 12, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, June 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 1, 2023ASSIGNED TO EXAMINER
Thursday, August 3, 2023NON-FINAL ACTION WRITTEN
Thursday, August 3, 2023NON-FINAL ACTION E-MAILED
Thursday, August 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 2, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, November 2, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, December 6, 2023ASSIGNED TO EXAMINER
Saturday, January 27, 2024SUSPENSION LETTER WRITTEN
Saturday, January 27, 2024LETTER OF SUSPENSION E-MAILED
Saturday, January 27, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 16, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED